MarketFriction

Niva Bupa Health Insurance Company Ltd

NSE NIVABUPA · BSE 544286 · General Insurance
₹72.98 -2.45%
NSE close2026-10-01
52 week range67.50 - 91.40
Market cap₹13,551 Cr.
P/E77.8
IPO 2024 · -1% since Microcap 250 Price band 20% Delivery 59.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9691,0261,3161,1241,3211,2581,6711,9321,5741,6112,2512,471
Expenses1,0271,0711,2151,2281,3871,2821,4201,8341,6271,7052,0692,287
Operating Profit-58-46100-103-66-2425198-53-94182184
OPM %-6%-4.4%8%-9%-5.0%-1.9%15%5%-3.4%-6%8%7%
Other Income505057847937-45-0187-1-0
Interest000000000000
Depreciation000000000000
Profit before tax-85157-19131320698-35-88181184
Tax %0%0%0%0%0%0%0%27%0%0%12%25%
Net Profit-85157-19131320671-35-88159138
EPS in Rs0.071.130.39-0.19-0.470.860.75
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8511,0571,4131,8772,8534,1155,3746,6957,907
Expenses8801,0941,4352,3283,1834,2285,2926,5347,689
Operating Profit-29-37-22-451-330-11383160218
OPM %-3.4%-3.5%-1.5%-24%-12%-2.7%1.5%2.4%2.8%
Other Income000281374224155223
Interest346000000
Depreciation16212227322925360
Profit before tax-48-62-50-1971382214127242
Tax %0%0%0%0%0%0%0%-3%
Net Profit-48-62-50-1971382214131174
EPS in Rs1.170.710.95
Dividend Payout %0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%36%33%28%
Compounded Profit Growth%36%127%-43%
Stock Price CAGR%%%-10%
Return on Equity%3%5%3%
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital9811,1261,3501,4091,5111,7001,8271,847
Reserves-719-780-773-903-6833511,9491,939
Borrowings000250250250250250
Other Liabilities7378911,3221,9832,7993,8915,7357,240
Total Liabilities1,0001,2371,8992,7383,8776,1929,76011,276
Fixed Assets3039464952586685
CWIP22214193
Investments8161,0671,6222,4013,3665,4588,1759,670
Other Assets1521292302874556751,5101,518
Total Assets1,0001,2371,8992,7383,8776,1929,76011,276
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity2573385938131,654905
Cash from Investing Activity-374-723-829-1,882-2,348-961
Cash from Financing Activity2803742801,110771-5
Net Cash Flow164-12434178-62
Free Cash Flow2293095557801,614857
CFO/OP-1,180%-75%-180%-720%2,000%577%
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days00000000
Inventory Days
Days Payable
Cash Conversion Cycle00000000
Working Capital Days-264-270-290-341-313-298-351-354
ROCE %-19%-10%-30%1%5%7%3%
Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters55.98%55.98%55.43%55.41%55.36%55.36%55.30%
FIIs8.85%8.90%10.76%10.72%10.31%10.60%12.09%
DIIs9.82%9.71%15.06%15.31%16.04%16.49%16.17%
Public25.36%25.42%18.74%18.57%18.27%17.56%16.44%
No. of Shareholders1,46,2551,36,0171,54,8831,58,5501,47,7181,35,3431,26,567

Fundamentals

Market Cap₹ 13,551 Cr.
Current Price₹ 73.3
Stock P/E77.8
Book Value₹ 20.5
ROCE3.15 %
ROE3.46 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)28%
Compounded Profit Growth (TTM)-43%
Standalone figures.
Valuation
Market capRs 12,403 Cr
Enterprise valueRs 12,510 Cr
P/E (TTM)71.18x
Price to book6.05x
Price to sales1.57x
EV / EBITDA46.17x
EV / EBIT51.79x
EV / sales1.58x
Price to cash flow15.26x
Earnings yield1.40%
Profitability
Operating margin (excl. other income)-2.74%
Operating margin (incl. other income)2.70%
EBITDA margin3.43%
Pre-tax margin3.06%
Net profit margin2.20%
Net margin, latest quarter5.58%
ROE5.69%
ROCE4.85%
ROA1.63%
ROE, 3-year average-9.58%
ROCE, 3-year average-7.76%
ROA, 3-year average-2.16%
ROE, 5-year average-11.95%
ROCE, 5-year average-10.34%
ROA, 5-year average-3.03%
ROIC (approx.)11.20%
Other income / net worth10.93%
Growth
Sales growth (latest year)44.25%
Profit growth (latest year)552.71%
Sales CAGR, 3 years42.81%
Sales CAGR, 5 years37.06%
Sales growth QoQ9.78%
Profit growth QoQ-13.53%
Sales growth YoY (latest quarter)27.93%
Profit growth YoY (latest quarter)92.89%
Per share
EPS (TTM)Rs 1.03
EPS (latest year)Rs 0.48
EPS (latest quarter)Rs 0.81
EPS, 3-year averageRs -0.28
EPS, 5-year averageRs -0.35
Book value per shareRs 12.07
Sales per shareRs 46.53
Cash flow per shareRs 4.78
Free cash flow per shareRs 5.04
Efficiency
Asset turnover0.66x
Fixed asset turnover70.59x
Cash conversion cycle0 days
Working capital days-354 days
Leverage
Total debtRs 250 Cr
Cash and bankRs 143 Cr
Net debtRs 107 Cr
Debt to equity0.12x
Net debt / EBITDA0.40x
Owners' fund to total sources33.12%
Debt to assets4.04%
Cash flow
Cash from Operating Activity (latest year)Rs 813 Cr
Cash from Investing Activity (latest year)Rs -1,882 Cr
Cash from Financing Activity (latest year)Rs 1,110 Cr
Net Cash Flow (latest year)Rs 41 Cr
Free cash flow (latest year)Rs 857 Cr
FCFE (approx.: FCF + change in debt)Rs 857 Cr
Cash from ops / profit, 5 years17.71x
Sales to cash flow5.06x
Statement figures
Net sales (TTM)Rs 7,907 Cr
Net sales (latest year)Rs 4,115 Cr
Sales (latest quarter)Rs 2,471 Cr
Operating profit excl. other income (latest year)Rs -113 Cr
Operating profit (latest quarter)Rs 184 Cr
Other income (TTM)Rs 23 Cr
EBITDA (TTM)Rs 271 Cr
PBDT (TTM)Rs 271 Cr
Profit before tax (TTM)Rs 242 Cr
Net profit (TTM)Rs 174 Cr
Net profit (latest year)Rs 82 Cr
Net profit (latest quarter)Rs 138 Cr
Depreciation (TTM)Rs 29 Cr
Cost of goods sold (latest year)Rs 3,000 Cr
Total expenditure (latest year)Rs 4,228 Cr
Total income (latest year)Rs 4,340 Cr
Share capitalRs 1,700 Cr
ReservesRs 351 Cr
Shareholders' fundsRs 2,051 Cr
Total assetsRs 6,192 Cr
Net blockRs 58 Cr
Capital work in progressRs 1 Cr
InvestmentsRs 5,458 Cr
Other liabilitiesRs 3,891 Cr
Shares outstanding (crore)169.95
Ownership
Promoter holding55.30% (-0.13 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 6.05 is the lowest in 2.0 years (median 16.19).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodNIVABUPANifty 50Difference
1 week-4.1%-2.8% -1.4 pts
1 month-11.3%-6.8% -4.5 pts
3 months-15.7%-7.6% -8.1 pts
6 months+3.9%+0.4% +3.5 pts
1 year-9.9%-9.9% +0.0 pts
47 mutual fund schemes hold about ₹1,378 Cr. Over three months 42 bought more and 3 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Nippon India Multi Cap Fund0.74%415 +11%
Axis Small Cap Fund0.67%211 +7%
DSP Small Cap Fund0.66%142 +3%
SBI ELSS Tax Saver Fund0.41%131 +15%
Tata Balanced Adv Fund1.19%104 +20%
Tata Multi Asset Allocation Fund1.42%75 +15%
SBI Banking & Financial Services Fund0.68%74 +14%
Tata Business Cycle Fund2.43%63 +31%
DSP Flexi Cap Fund0.41%51 +12%
Nippon India Innovation Fund0.85%26 +7%
Nippon India Flexi Cap Fund0.18%18 +11%
Bajaj Finserv Small Cap Fund0.66%17 -5%
Bajaj Finserv Banking and Financial Services Fund2.34%12 +43%
Axis Services Opportunities Fund0.67%10 +24%
Nippon India Nifty Smallcap 250 Index Fund0.23%8 +10%
SBI Nifty Smallcap 250 Index Fund0.23%4 +10%
The Wealth Company Mid Cap Fund1.97%3 +100%
Motilal Oswal Nifty Smallcap 250 Index Fund0.23%3 +10%
ICICI Pru Nifty Smallcap 250 Index Fund0.23%2 +10%
HDFC NIFTY Smallcap 250 Index Fund0.23%2 +10%
WSIF Equity Ex-Top 100 Long-Short Fund2.95%1 +100%
Nippon India Nifty 500 Equal Weight Index Fund0.19%1 +13%
JioBlackRock Nifty Smallcap 250 Index Fund0.23%1 +10%
WSIF Equity Long-Short Fund2.49%1 +100%
Motilal Oswal Nifty 500 Index Fund0.03%1 +10%

Red flags

F-score 6 of 8
explainShare dilution Share count up 13% in a year, 26% in three
lookProfit leans on other income Other income was 274% of pre-tax profit in 2026
lookRegulator order or action Regulator order or action 2026-08-20: Niva Bupa Health Insurance Company Limited has informed the Exchange about receipt of the Order from the Insurance Regulatory and Developmen
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹2,471 Cr +27.9% vs Jun 2025. Net profit ₹138 Cr +94.4%.

Activity

Compare
No bulk or block deals on record.
No corporate actions on record.
DateTypeWhat it says
2026-09-24Concall / analyst meetSchedule of meet
2026-09-17Credit RatingCredit Rating
2026-09-16CessationChange in Management of the Company w.e.f September 16, 2026
2026-09-16AppointmentChange in Management of the Company w.e.f September 16, 2026
2026-09-16General UpdatesGeneral Updates - ESG Rating
2026-08-26ESOPAllotment of 4,11,000 Equity Shares.
2026-08-20Credit RatingCredit Rating
2026-08-20Regulatory actionReceipt of the Order from the Insurance Regulatory and Development Authority of India
2026-08-13Shareholder meetingNiva Bupa Health Insurance Company Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 12, 2026
2026-08-12Shareholder meetingProceedings of Annual General Meeting held on August 12, 2026
2026-08-11UpdatesReceipt of approval from Insurance Regulatory and Development Authority of India ( IRDAI ) for appointment of Mr. Ashwani Bhatia (DIN: 07423221) as th...
2026-08-03Concall / analyst meetTranscript
2026-07-30Concall / analyst meetLink of Recording
2026-07-30Press ReleaseA press release on Unaudited financial results for quarter ended June, 2026.
2026-07-30Investor PresentationInvestor Presentation
2026-07-30Board meeting outcomeOutcome of Board meeting on approval of fund raising by issuance of Non-convertible debentures.
2026-07-30Board meeting outcomeOutcome of Board meeting on approval of financial results for quarter ended June, 2026.
2026-07-27Concall / analyst meetSchedule of meet
2026-07-17General UpdatesNiva Bupa Health Insurance Company Limited has submitted BRSR for the Financial Year ended March 31, 2026
2026-07-17Shareholder meetingNotice of Annual General Meeting to be held on August 12, 2026
2026-07-15Credit Rating- NewIssuer Rating assigned by the ICRA Limited
2026-07-15LitigationUpdate on pending litigation(s)/dispute(s) or the outcome impacting the Company
2026-06-23ESOPAllotment of 1476432 Shares.
2026-06-23Credit RatingCredit Rating
2026-06-03ResignationResignation of Director/KMP/SMP
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Niva Bupa Health Insurance Company Ltd?

Niva Bupa Health Insurance Company Ltd (NIVABUPA) has a market capitalisation of Rs 13,551 Cr. at the 2026-10-01 close.

What is the P/E ratio of Niva Bupa Health Insurance Company Ltd?

Niva Bupa Health Insurance Company Ltd trades at a P/E of 77.8 on trailing twelve-month profit, at the 2026-10-01 close.

What were Niva Bupa Health Insurance Company Ltd's latest quarterly results?

In the Jun 2026 quarter, Niva Bupa Health Insurance Company Ltd sales was Rs 2,471 Cr (+27.9% vs Jun 2025) and net profit was Rs 138 Cr.

What is the 52-week high and low of Niva Bupa Health Insurance Company Ltd?

The 52-week high is Rs 91.40 and the 52-week low is Rs 67.50.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03